Clinical Trial Update: Safety and Efficacy of NK510 to Treat NSCLC [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update indicates NK510 is being investigated for non-small cell lung cancer in an early-phase study and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• NK510

Snippet

Sponsor: Base Therapeutics (Shanghai) Co., Ltd. | Conditions: NSCLC | EARLY_Phase 1 | Status: RECRUITING